Company

Committed to improving the lives of patients with respiratory conditions

We’re a biopharmaceutical company developing innovative prescription medicines.

Our Vision

Meeting unmet medical needs

Our goal is to improve the lives of those affected by the burden of chronic respiratory diseases. We are committed to delivering our treatments to the millions of patients suffering from respiratory diseases as quickly as possible.

Our Strategy

Agile and flexible approach

We are focused on developing ensifentrine, which we believe has the potential to become an important and novel treatment for lung diseases.

Company Leadership

In 2025, we will continue to build on the successful commercialization of Ohtuvayre® (ensifentrine) in the US while progressing our Phase 2 programs. We are also initiating activities with regulatory authorities in the European Union and the UK for potential marketing authorization application submissions for Ohtuvayre.

Careers

Hiring outstanding individuals

We are expanding rapidly and seeking exceptional people to join our team. Explore career opportunities at Verona.

Corporate Governance

Verona’s Board of Directors sets high standards for our employees, officers and directors and good corporate governance is implicit in these values. Learn more here.

Developing novel therapeutics for respiratory diseases

To learn more about Verona Pharma, please get in touch.

Close up of female doctor hold woman patient hands help on personal therapy session, psychologist or counselor show understanding and care, support depressed suffering client on treatment